MAPK10 and Alzheimer disease: Aβ can induce neurodegeneration, at least in part, through the JNK3 pathway (Braithwaite et al., 2010), suggesting that inhibition of JNK3 activity may be of therapeutic utility in the treatment of AD (Resnick & Fennell, 2004).